ginsenoside rh2 has been researched along with Endometrial Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH; Kim, K; Kim, M; Kim, YB; Lee, S; No, JH; Suh, DH; Yun, SM | 1 |
1 other study(ies) available for ginsenoside rh2 and Endometrial Neoplasms
| Article | Year |
|---|---|
Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Topics: Apoptosis; Cadherins; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Epithelial-Mesenchymal Transition; Female; Ginsenosides; Humans; In Situ Nick-End Labeling; Signal Transduction; Transforming Growth Factor beta; Vimentin | 2017 |